Mefloquine Shows Promise Against Schistosomiasis in Mice
Author Information
Author(s): Jennifer Keiser, Jacques Chollet, Shu-Hua Xiao, Jin-Yan Mei, Pei-Ying Jiao, Jürg Utzinger, Marcel Tanner
Primary Institution: Swiss Tropical Institute, Basel, Switzerland
Hypothesis
Can mefloquine, an antimalarial drug, effectively reduce schistosomiasis in mice?
Conclusion
Mefloquine significantly reduced worm burdens in mice infected with schistosomiasis, suggesting its potential as a new treatment.
Supporting Evidence
- Mefloquine reduced total and female worm burdens by 72.3% to 100%.
- Both enantiomers of mefloquine showed comparable efficacy against schistosomiasis.
- Significant differences in worm burden were observed between treated and untreated mice.
Takeaway
Mefloquine, a drug used for malaria, might also help treat a disease called schistosomiasis in mice by killing the worms that cause it.
Methodology
Mice were given a single oral dose of mefloquine and then infected with schistosomiasis to measure worm burden reductions.
Limitations
The study was conducted in mice, and results may not directly translate to humans.
Participant Demographics
Mice (290 NMRI strain and 125 Kunming strain) were used in the experiments.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website